Cystic fibrosis, also known as mucoviscidosis is a genetic disorder where the autosomal recessive gene is affected. The disease affects the lungs, heart, pancreas, liver and intestines. It is characterized by abnormal transport of sodium and chloride through epithelium, making the secretions thick and viscous. Managing cystic fibrosis symptoms can be very difficult for most sufferers.
The name refers to scarring (fibrosis) and cyst formation within the pancreas that was first documented in 1930s. Due to the abnormal secretions, lung infections are frequent and breathing difficulty is the most serious symptom. Other cystic fibrosis symptoms are: poor growth, enlarged heart, sinus infections, respiratory pulmonary diseases, digestive problems, infertility and abnormal pancreas function.
The first indication of cystic fibrosis are salty skin, poor growth and weight gain despite normal food intake. Others are thick sticky mucus, frequent respiratory infections, persistent cough and shortness of breath.
Lung and sinus infections result from clogging because of the thick sticky mucus, reduce ciliary mobility and inflammation.
Inflammation and repeated infections cause structural changes in the lungs leading to many symptoms. In early stages, there is constant coughing, increase phlegm production and decrease resistance to effort and physical exercise. In later stages, when structural changes in the lungs and airways occur, there are breathing difficulties. There is a difficulty in getting enough oxygen to the blood (hypoxia). Coughing up blood, recurrent pneumonia, high blood pressure in the lungs, respiratory failure, heart failure, are other serious symptoms.
The para nasal passages and sinuses may also be affected due to the thick mucus. Sinus infections are common, together with their symptomatology: headache, facial pain, fever, nasal drainage. Nasal polyps are also very common to develop as a result of multiple sinus infections. Cardio-respiratory complications are the most cause of death in people with cystic fibrosis.
Life with Cystic Fibrosis
The lungs of persons with cystic fibrosis are infected and colonized with bacteria from an early age. These types of bacteria and their characteristics change and develop in time. They have a perfect environment in the thick viscous mucus and they develop resistance to commonly used antibiotics. More often these types of flourishing bacteria are spread between different individuals with cystic fibrosis. People with cystic fibrosis have to be aware of this danger and avoid spreading these dangerous strains of bacteria among other sufferers. In healthcare facilities, people with cystic fibrosis should be isolated from one another. Strict hygiene should be maintained to avoid spreading strains of bacteria among them.
Beside uncommon strains of bacteria, different types of fungi and/or yeasts can chronically colonized the airways. Some of them are found almost exclusively in patients with cystic fibrosis. Defective mucous-ciliary clearance favourites the growth of these colonies, together with prolonged antibiotic and corticosteroid therapies that also favourite their growth.
The respiratory complications can be reduced by using salt therapy. Hyper-tonic saline solution is used in hospitals to help in clearing the thick stagnant mucus and avoid infection. The long-term salt aerosol exposure in home salt therapy is very beneficial in managing cystic fibrosis. It provides exposure during the night sleep, when the salt micro-particles slowly deposit on the respiratory mucosa. It helps to make the thick mucus more fluid, unclogs the airways and reduces inflammation. Salt is known to have bactericide properties and helps in fighting infections, beside its mucolytic and anti inflammatory effect. Using a home salt therapy device will create a seashore micro-environment in your own house. It is very easy to use, natural and effective!